DQP 1105 |
| Catalog No.GC10085 |
Le DQP 1105 est un puissant antagoniste non compétitif des récepteurs NMDA.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 380560-89-4
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 380560-89-4 | SDF | |
| Chemical Name | 4-((R)-5-(4-bromophenyl)-3-((R)-6-methyl-2-oxo-4-phenyl-2,3-dihydroquinolin-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-oxobutanoic acid | ||
| Canonical SMILES | BrC1=CC=C(C=C1)[C@@H]2N(C(CCC(O)=O)=O)N=C([C@H]3C(C4=CC=CC=C4)=C(C=C(C)C=C5)C5=NC3=O)C2 | ||
| Formula | C29H24BrN3O4 | M.Wt | 558.42 |
| Solubility | <55.84mg/ml in DMSO | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.7908 mL | 8.9538 mL | 17.9077 mL |
| 5 mM | 0.3582 mL | 1.7908 mL | 3.5815 mL |
| 10 mM | 0.1791 mL | 0.8954 mL | 1.7908 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC15292 (S)-(+)-Niguldipine hydrochloride
- GC43147 CAY10398
- GC33981 Lomefloxacin (SC47111A)
- GC31684 Dithranol (Anthralin)
- GC14749 ALLO-1
- GC36530 MAGE-A3 195-203
- GC31385 Lith-O-Asp
- GC15745 Mps1-IN-2
- GC33866 Resorcinol monoacetate (Acetylresorcinol)
- GC39816 WAY-181187
- GC30198 Dolasetron Mesylate hydrate
- GC30011 20-Deoxyingenol
- GC12088 BAY-678
- GC44346 N-Desethylamiodarone (hydrochloride)
- GC30421 Enalapril D5 maleate (MK-421 (D5 maleate))
- GC43025 C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0)
- GC10007 LX1606 Hippurate (Telotristat etiprate)
Avis
Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *